Navigation Links
NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region
Date:7/22/2009

ss sales and marketing, pharmacovigilance and supply chain support for our innovative products allows patients and physicians across the region access to best-in-class therapeutics, education and support."

"We are happy to be partnering with NewBridge Pharmaceuticals," said Nicholas Franco, Axcan's Senior Vice President, International Commercial Operations, "which will enable Axcan's Pylera to be launched in rapidly growing markets in which NewBridge has expertise."

About Helicobacter pylori

The discovery in 1983 of the Helicobacter pylori organism was one of the major advances in gastroenterology in recent decades, as it has revolutionized the approach to many upper gastrointestinal disorders. Helicobacter pylori is believed to cause a spectrum of diseases in humans, including gastritis, ulcer disease (gastric and duodenal), gastric cancer and gastric lymphoma. In North-America, 10% of the population will have an ulcer in their lifetime; and many treatments end up with a high rate of recurrences. In fact, 40% to 80% of patients experience a recurrence within only a year after undergoing short-term treatment of gastric acid suppression therapy. Studies have shown that the gastroduodenal reoccurrence rate is only 2% for patients in whom the organism has been eradicated.

About NewBridge Pharmaceuticals

NewBridge Pharmaceuticals (www.nbpharma.com) is a specialty pharmaceutical, biologics, and medical device company serving the Middle East, Africa, Turkey, and Caspian regions to address the unmet needs of diseases with high regional prevalence such as cancer, diabetes, obesity, cardiovascular diseases and other metabolic disorders. NewBridge in-licenses and commercializes FDA and EMEA approved therapeutics, medical devices and diagnostics. Headquartered in UAE with Business Development in the US, NewBridge was founded in 2007 by Burrill & Comp
'/>"/>

SOURCE NewBridge Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Newbridge Securities Corporation Forms BioVentures Division
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... and SAN JOSE, California , January 15, ... developing antibody-drug conjugates for cancer, today announced the appointment of ... Dr Reynolds has over 20 years, development experience gained in ... Seattle Genetics. "I am delighted to welcome Tom ...
(Date:1/15/2014)... 15, 2014 Two champions of science, ... sponsorship of an annual competition for middle and high ... to, innovative STEM study. The competition presents students with ... of Engineering Aptitude, Mathematics, and Sciences is a ...
(Date:1/15/2014)... January 15, 2014 AudioNotch is the ... therapy for the treatment of tinnitus. Patients listen to ... and over a period of weeks to months, their tinnitus ... in two forms: Notched Music and Notched White Noise. Now, ...
(Date:1/14/2014)... Communications, a leading provider of strategic communications services to corporations and ... the United States and Europe ... JD, is returning to the firm,s Washington, D.C. ... more than two years of service as Associate Commissioner for the ...
Breaking Biology Technology:Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Former FDA Associate Commissioner Returns To 3D Communications 2
... but it happens every year twice, in fact, as I ... no exception. , ,After four months of interviewing more than ... turn the raw ingredients of the selected companies into a cohesive ... business development execs who come to the event each year. , ...
... Wis.-based Fiserv, Inc., will expand its services to the ... the company announced Tuesday. , ,Through a multi-year agreement ... MetaVance Administration & Finance Application and hosting services, aimed ... this new solution to provide greater insights into business ...
... Wis. Berbee Information Networks ... "Small Business Specialist" in Madison, the company ... access to training specifically designed for the ... partner offers, and the ability to use ...
Cached Biology Technology:DEMOfall - A return to simplicity 2DEMOfall - A return to simplicity 3
(Date:4/24/2014)... very pleased to announce that it has assumed ownership ... the University of Wisconsin. , The Journal ... peer-reviewed journal that publishes papers on all aspects of ... the molecular to the ecological -- as well as ... to individuals and institutions, and it provides a reasonably ...
(Date:4/24/2014)... offsetting initiatives could be improved with new insights into ... , Scientists studying the Amazon Basin have revealed unprecedented ... across the region by comparing satellite maps with hundreds ... researchers to assess more accurately the amount of carbon ... in carbon offset schemes, in which trees are given ...
(Date:4/23/2014)... of NASA satellite data shows Africa,s Congo rainforest, the ... large-scale decline in greenness over the past decade. , ... Albany, State University of New York, shows between 2000 ... forest area and intensified. The research, published Wednesday in ... observational studies to explore the effects of long-term drought ...
Breaking Biology News(10 mins):ESA to publish the Journal of Insect Science 2Amazon rainforest survey could improve carbon offset schemes 2NASA satellites show drought may take toll on Congo rainforest 2NASA satellites show drought may take toll on Congo rainforest 3
... way to synthesize a cancer-killing compound called rasfonin in enough ... fungus discovered clinging to the walls of a New Zealand ... leaving healthy cells untouched. , "In 2000, scientists in Japan ... a prototype anticancer agent, but no one has been able ...
... lung tumors in some human patients just 3-4 months ... University of Pittsburgh Medical Center will report in early ... Association of Physicists in Medicine in Orlando. Although ... effectiveness, Ozhasoglu and his colleagues find promise in this ...
... Institute-led team has identified a molecule that plays a ... each side of the adult brain. , QBI ... her group's research provided new clues regarding development of ... shuttles information between the left and right hemispheres of ...
Cached Biology News:New lab technique churns out fungus' potential cancer fighter 2Radiation-armed robot rapidly destroys human lung tumors 2
...
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications)....
... siRNA Custom Synthesis Service provides ... RNA to knockdown any gene. ... RNA base pairs with terminal ... or other lengths of your ...
Alexa Fluor 647 anti-mouse Qa-2...
Biology Products: